本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

6.18
+0.28004.75%
盘后6.180.00000.00%17:20 EDT
成交量:82.93万
成交额:513.47万
市值:4.99亿
市盈率:-3.06
高:6.30
开:5.84
低:5.78
收:5.90
数据加载中...
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/17

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/06/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]